MENU
SLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Silence Therapeutics (SLN) Ownership - Who owns Silence Therapeutics?
Profile
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
283.29M
P/E Ratio
N/A
Total Cash
128.99M
Projected Growth
N/A
Total Debt
139K
Revenue
16.25M
Risk (Beta)
1.25
Dividend Yield
N/A
Total Cash/Share
2.73
Total Debt/Equity
N/A
Revenue/Share
0.46 USD as % of share price
Fundamentals
SLN
Capitalization
283M
P/E Ratio
N/A
Risk (Beta)
1.25
Dividend Yield
N/A
Total Cash
129M
Total Cash/Share
2.73
Total Debt
139K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.46%
Revenue
16.2M
ROE
N/A
Book Value
94.5M
P/B Ratio
2.67
Cash Flow
N/A
Earnings
-1.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.08M
Current Ratio
9.31
Current Revenue Per Employee
10477.06
Dividends Per Share - Security
N/A
EBITDA
-56.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
-142.91
Revenue To Assets
-44.04
Shares Held By Institutions
501M
Shares Outstanding - Current
47.2M
Total Liabilities
74.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-62.522
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com